[go: up one dir, main page]

MX2010008144A - Metodos y composiciones para el tratamiento de afecciones oseas. - Google Patents

Metodos y composiciones para el tratamiento de afecciones oseas.

Info

Publication number
MX2010008144A
MX2010008144A MX2010008144A MX2010008144A MX2010008144A MX 2010008144 A MX2010008144 A MX 2010008144A MX 2010008144 A MX2010008144 A MX 2010008144A MX 2010008144 A MX2010008144 A MX 2010008144A MX 2010008144 A MX2010008144 A MX 2010008144A
Authority
MX
Mexico
Prior art keywords
treatment
methods
compositions
bone conditions
present
Prior art date
Application number
MX2010008144A
Other languages
English (en)
Inventor
Anne Schaafsma
Cornelis Glas
Elisabeth Gertruda Hendrika Maria Van Den Heuvel
Original Assignee
Friesland Brands Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Friesland Brands Bv filed Critical Friesland Brands Bv
Publication of MX2010008144A publication Critical patent/MX2010008144A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se relaciona con métodos y composiciones para el tratamiento de afecciones óseas, especialmente la pérdida ósea como la osteoporosis. La presente invención se relaciona especialmente a composiciones nutricionales a base de leche preferentemente complementadas con prebióticos y una fuente de vitamina K2 separada, y métodos que usan las composiciones nutricionales para el tratamiento o profilaxis de las afecciones óseas especialmente la pérdida ósea como la osteoporosis. La presente composición comprende: una o más fracciones y/o componentes derivados de leche; preferentemente uno o más prebióticos: preferentemente una o más sales de calcio y/o magnesio; y vitamina K2 (menaquinona) la cual comprende 7 a 13 (MK-7 a MK 13) residuos de isopropenoide.
MX2010008144A 2008-01-28 2009-01-27 Metodos y composiciones para el tratamiento de afecciones oseas. MX2010008144A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1034964A NL1034964C2 (nl) 2008-01-28 2008-01-28 Werkwijze en composities voor de behandeling van botaandoeningen.
PCT/EP2009/000578 WO2009095240A1 (en) 2008-01-28 2009-01-27 Methods and compositions for the treatment of bone conditions

Publications (1)

Publication Number Publication Date
MX2010008144A true MX2010008144A (es) 2010-08-04

Family

ID=39727769

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010008144A MX2010008144A (es) 2008-01-28 2009-01-27 Metodos y composiciones para el tratamiento de afecciones oseas.

Country Status (6)

Country Link
EP (1) EP2247199A1 (es)
CN (1) CN101969792A (es)
EA (1) EA020252B1 (es)
MX (1) MX2010008144A (es)
NL (1) NL1034964C2 (es)
WO (1) WO2009095240A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2419506T3 (en) * 2009-04-15 2018-01-15 Dupont Nutrition Biosci Aps BAKERY STUMS WITH AN EXCELLENT ABILITY TO MAKE MENAQUINON
IN2012DN02245A (es) * 2009-09-14 2015-05-22 Nestec Sa
WO2011150949A1 (en) 2010-06-04 2011-12-08 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
CN103179863A (zh) * 2010-08-17 2013-06-26 科.汉森有限公司 高产维生素k2的乳酸乳球菌菌株
US8673616B2 (en) 2010-08-17 2014-03-18 Chr. Hansen A/S Lactococcus lactis strain with high vitamin K2 production
EP2709460A1 (en) * 2011-05-20 2014-03-26 Friesland Brands B.V. Composition comprising vitamin k2
NL2008294C2 (en) * 2011-05-20 2013-08-19 Friesland Brands Bv Food composition comprising vitamin k and saturated fat.
WO2013144267A2 (en) * 2012-03-29 2013-10-03 Nestec S.A. Improvement of musculoskeletal health by nutrition and exercise
WO2013144268A1 (en) * 2012-03-29 2013-10-03 Nestec S.A. Nutrition and exercise against drug-associated malnutrition in children
JP6811614B2 (ja) * 2014-05-05 2021-01-13 ビーエイエスエフ・ソシエタス・エウロパエアＢａｓｆ Ｓｅ 脂溶性ビタミン製剤
ITUA20163791A1 (it) * 2016-05-25 2017-11-25 Alfonso Colacchio Composto nutraceutico per il potenziamento del sistema immunitario ed il benessere delle ossa
CN106615099A (zh) * 2016-10-12 2017-05-10 西宝生物科技（上海）股份有限公司 一种包含mk‑7和活性维生素d3的酸奶及其制备方法
AU2017394752B9 (en) 2017-01-23 2020-05-28 Cupione Co., Ltd. Composition for preventing or treating osteoarthritis containing sialyllactose or salt thereof as active ingredient
US20200338031A1 (en) * 2019-04-26 2020-10-29 Lanny Leo Johnson Compositions for the treatment of non-articular cartilage-associated bone conditions
EP4285997A4 (en) * 2021-01-26 2025-04-16 Megmilk Snow Brand Co. Ltd. COMPOSITION TO IMPROVE JOINT FUNCTION
WO2024240923A1 (en) * 2023-05-25 2024-11-28 Société des Produits Nestlé S.A. Prebiotics for treating and/or preventing vitamin k2 deficiency

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9401958A (nl) * 1994-11-23 1996-07-01 Friesland Brands Bv Met eierschalenmeel verrijkt melkprodukt.
NZ507335A (en) * 2000-10-05 2004-10-29 New Zealand Dairy Board Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP
GB0100273D0 (en) * 2001-01-08 2001-02-14 Nestle Sa Nutritional composition for a bone condition
JP2006213627A (ja) * 2005-02-02 2006-08-17 Isamu Kajima 骨粗鬆症発症予防剤
WO2008006607A2 (en) * 2006-07-14 2008-01-17 Nattopharma Asa Pharmaceutical and nutraceutical products comprising vitamin k2

Also Published As

Publication number Publication date
EA201070893A1 (ru) 2011-02-28
EP2247199A1 (en) 2010-11-10
WO2009095240A1 (en) 2009-08-06
CN101969792A (zh) 2011-02-09
EA020252B1 (ru) 2014-09-30
NL1034964C2 (nl) 2009-07-30

Similar Documents

Publication Publication Date Title
MX2010008144A (es) Metodos y composiciones para el tratamiento de afecciones oseas.
MY152282A (en) Compositions and methods for use antibodies against sclerostin
PH12014500558A1 (en) Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease
EP2528578A4 (en) DENTAL COMPOSITION USING A CALCIUM SOURCE
MY158467A (en) Heat transfer compositions
MX2009008099A (es) Compuestos para la prevencion y tratamiento de enfermedades cardiovasculares.
MX367367B (es) Sales de arginina y sus usos para el tratamiento de enfermedades en la cavidad oral.
SG10201805198TA (en) 18f - fluciclovine compositions in citrate buffers
IL222787A0 (en) Process for preparing nebivolol
MX348325B (es) Composicion que contiene galacto-oligosacarido y un metodo para producirla.
ATE486497T1 (de) Frittierfettzusammensetzung
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
MX2010004642A (es) Procedimiento para reducir el contenido en acidos grasos saturados de la grasa de leche, productos obtenidos y aplicaciones del mismo.
HK1216085A1 (zh) 形成水泥的组合物、三斜磷钙石水泥、植入物及用於矫正骨缺损的方法
MY149433A (en) Nutritional compositions containing punicalagins
MX2012012095A (es) Analogos de tiazolidinadiona.
WO2011147034A8 (en) Prostaglandin-bisphosphonate conjugate compounds, methods of making same, and uses thereof
MX2011008645A (es) Inhibidores de tetrahidrotiazolopiridina de fosfatidilinositol 3 cinasa.
WO2012057836A3 (en) Composites of hydroxyapatite and calcium carbonate and related methods of preparation and use
MY177020A (en) Compositions and methods for maintaining bone heal th or reducing bone loss
BR112013003698A2 (pt) composições de goma de umedecimento oral e produtos contendo as mesmas
MX2012014071A (es) Composicion farmaceutica estable para el tratamiento de osteoporosis.
IL174477A0 (en) Calcium enrichement compositions and methods of production thereof
WO2009086952A3 (en) Compositions for the treatment of degenerative articular diseases
MX2010004139A (es) Granulos secados por rocio, metodo de produccion de los mismos y composicion detergente granular que contiene los granulos secados por rocio.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal